Serdexmethylphenidate/Dexmethylphenidate

丝右哌甲酯/右哌甲酯

Report date: 2026/05/13 20:02:10

Base Information

Drug NameSerdexmethylphenidate/Dexmethylphenidate
Drug Alias Name丝右哌甲酯右哌甲酯复方胶囊Methylphenidate prodrugD-threo-methylphenidate prodrug (KemPharm)复方氯丝右哌甲酯Serdexmethylphenidate chloride (KemPharm) +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha adrenergic receptor agonistsDopamine transporter antagonistsNorepinephrine transporter inhibitors +[5] 
TargetsAlpha adrenergic receptorNorepinephrine transporterDopamine transporter +[4] 
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsAttention Deficit Disorder with Hyperactivity
Approved Indications in ChinaAttention Deficit Disorder with Hyperactivity
Original Approved Country/TerritoryUnited States
Original Approved Date2021/03/02
Country/TerritoryUnited StatesMainland China
CombinationsYes Dexmethylphenidate HydrochlorideSerdexmethylphenidate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesZevra Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCollegium Pharmaceutical IncCommcave Therapeutics SA
Inactive CompaniesCatalent Greenville IncZevra Therapeutics IncCommave Therapeutics SA +[4] 
Active IndicationsAttention Deficit Disorder with Hyperactivity
Inactive IndicationsN/A

Other Information

ATC CodeN06BA11
Related LinksWikipediaDrugBankKEGG